Predicting risk for new-onset type 2 diabetes in Chinese people with coronary heart disease and impaired glucose tolerance

Bibliographische Detailangaben
Hauptverfasser:	Xu, S, Scott, C, Coleman, RL, Tuomilehto, J, Holman, RR
Format:	Conference item
Sprache:	English
Veröffentlicht:	Springer Nature 2019

Predicting the risk of developing type 2 diabetes in Chinese people who have coronary heart disease and impaired glucose tolerance
von: Xu, S, et al.
Veröffentlicht: (2021)

Predicting heart failure events in patients with coronary heart disease and impaired glucose tolerance: insights from the Acarbose Cardiovascular Evaluation (ACE) trial
von: Wamil, M, et al.
Veröffentlicht: (2020)

Health utilities in Chinese patients with coronary heart disease and impaired glucose tolerance (ACE): a longitudinal analysis of a randomized, double-blind, placebo-controlled trial
von: Leal, J, et al.
Veröffentlicht: (2022)

Effects of acarbose on cardiovascular and diabetes outcomes in patients with coronary heart disease and impaired glucose tolerance (ACE): a randomised, double-blind, placebo-controlled trial
von: Holman, R, et al.
Veröffentlicht: (2017)

Effect of valsartan on kidney outcomes in people with impaired glucose tolerance.
von: Currie, G, et al.
Veröffentlicht: (2017)

Increased risk of incident heart failure and all-cause mortality in insulin-resistant people with type 2 diabetes in the United Kingdom Prospective Diabetes Study (UKPDS)
von: Wamil, M, et al.
Veröffentlicht: (2020)

Comparison of medical resources and costs among patients with coronary heart disease and impaired glucose tolerance in the Acarbose Cardiovascular Evaluation trial
von: Liam Mc Morrow, et al.
Veröffentlicht: (2024-02-01)

Prevalence of Impaired Fasting Glucose and Impaired Glucose Tolerance in Non-Diabetic Patients with Coronary Artery Disease
von: Nihar Ranjan Mohanty, et al.
Veröffentlicht: (2022-06-01)

Increased risk of incident heart failure and death is associated with insulin resistance in people with newly diagnosed type 2 diabetes: UKPDS 89
von: Wamil, M, et al.
Veröffentlicht: (2021)

People at increased risk of cardiovascular disease screened for the NAVIGATOR trial frequently have undiagnosed diabetes or impaired glucose tolerance
von: Califf, R, et al.
Veröffentlicht: (2003)

Prevention of diabetes and cardiovascular disease in patients with impaired glucose tolerance: rationale and design of the Nateglinide And Valsartan in Impaired Glucose Tolerance Outcomes Research (NAVIGATOR) Trial.
von: Califf, R, et al.
Veröffentlicht: (2008)

Adipokine pattern in subjects with impaired fasting glucose and impaired glucose tolerance in comparison to normal glucose tolerance and diabetes.
von: Anke Tönjes, et al.
Veröffentlicht: (2010-01-01)

Association between change in daily ambulatory activity and cardiovascular events in people with impaired glucose tolerance (NAVIGATOR trial): a cohort analysis.
von: Yates, T, et al.
Veröffentlicht: (2014)

Association between change in daily ambulatory activity and cardiovascular events in people with impaired glucose tolerance (NAVIGATOR trial): A cohort analysis
von: Yates, T, et al.
Veröffentlicht: (2014)

Framingham risk equations underestimate coronary heart disease risk in diabetes.
von: Stevens, R, et al.
Veröffentlicht: (2005)

Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial.
von: Gerstein, H, et al.
Veröffentlicht: (2006)

Perceived Symptoms in People Living with Impaired Glucose Tolerance
von: Susanne Andersson, et al.
Veröffentlicht: (2011-01-01)

Florid diabetic complications in impaired glucose tolerance
von: Anil P Bhatt, et al.
Veröffentlicht: (2013-01-01)

Association between impaired glucose tolerance and circulating concentration of Lp(a) lipoprotein in relation to coronary heart disease.
von: Farrer, M, et al.
Veröffentlicht: (1993)

Maintenance of basal plasma glucose and insulin concentrations in maturity-onset diabetes.
von: Holman, R, et al.
Veröffentlicht: (1979)

Oxidative injury and neuropathy in diabetes and impaired glucose tolerance
von: James W. Russell, et al.
Veröffentlicht: (2008-06-01)

Impaired Secretion of Total Glucagon-like Peptide-1 in People with Impaired Fasting Glucose Combined Impaired Glucose Tolerance
von: Fang Zhang, Xialian Tang, Hongyi Cao, Qingguo Lü, Nali Li, Yupu Liu, Xiangxun Zhang, Yuwei Zhang, Mingming Cao, Jun Wan, Zhenmei An, Nanwei Tong
Veröffentlicht: (2012-01-01)

Modelling incremental benefits on complications rates when targeting lower HbA1c levels in people with Type 2 diabetes and cardiovascular disease
von: Mostafa, SA, et al.
Veröffentlicht: (2017)

Predictors of stroke in patients with impaired glucose tolerance: results from the Nateglinide and Valsartan in Impaired Glucose Tolerance Outcomes Research trial.
von: Preiss, D, et al.
Veröffentlicht: (2013)

FASTING BLOOD-GLUCOSE CONCENTRATIONS AND TREATMENT OF MATURITY-ONSET DIABETES
von: Howedavies, S, et al.
Veröffentlicht: (1980)

Expert Workshop on Impaired Glucose Tolerance Held in London, UK - 29 March 1995 - Introduction
von: Holman, R
Veröffentlicht: (1996)

Effect of Apple Consumption on Postprandial Blood Glucose Levels in Normal Glucose Tolerance People versus Those with Impaired Glucose Tolerance
von: Yutaka Inoue, et al.
Veröffentlicht: (2022-06-01)

Identification of Significant Predictors for the Need of Insulin Therapy and Onset of Postpartum Impaired Glucose Tolerance in Gestational Diabetes Mellitus Patients
von: Wang T, et al.
Veröffentlicht: (2021-06-01)

Evidence From a Systematic Review and Meta-Analysis: Classical Impaired Glucose Tolerance Should Be Divided Into Subgroups of Isolated Impaired Glucose Tolerance and Impaired Glucose Tolerance Combined With Impaired Fasting Glucose, According to the Risk of Progression to Diabetes
von: Yupu Liu, et al.
Veröffentlicht: (2022-02-01)

Comparison of in vivo tests for glucose tolerance in subjects with normal, impaired glucose tolerance and type 2 diabetes
von: Hermans, M, et al.
Veröffentlicht: (1996)

New-onset diabetes after transplantation and oral glucose tolerance test
von: Somsri Wiwanitkit, et al.
Veröffentlicht: (2014-01-01)

The basal plasma glucose: a simple relevant index of maturity-onset diabetes.
von: Holman, R, et al.
Veröffentlicht: (1981)

CONTROL OF MATURITY-ONSET DIABETES BY HOME OR CLINIC MONITORING OF FASTING PLASMA GLUCOSE
von: Howedavies, S, et al.
Veröffentlicht: (1978)

Predicting post one-year durability of glucose-lowering monotherapies in patients with new-onset type 2 diabetes
von: Agbaje, O, et al.
Veröffentlicht: (2017)

Variations in the ghrelin receptor gene associate with obesity and glucose metabolism in individuals with impaired glucose tolerance.
von: Ursula Mager, et al.
Veröffentlicht: (2008-08-01)

Relationship between BMI and risk of impaired glucose tolerance and impaired fasting glucose in Chinese adults: a prospective study
von: Xin Zhang, et al.
Veröffentlicht: (2023-01-01)

Dyslipidemia, metabolic syndrome, and liver enzymes in impaired glucose tolerance and new onset untreated, type 2 diabetes Indian subjects
von: Debmalaya Sanyal, et al.
Veröffentlicht: (2012-01-01)

Coronary heart disease incidence and mortality, and all-cause mortality among diabetic and non-diabetic people according to their smoking behavior in Finland
von: Noël C. Barengo, et al.
Veröffentlicht: (2017-02-01)

Prevalence of diabetes mellitus and impaired glucose tolerance in parents of women with gestational diabetes.
von: McLellan, J, et al.
Veröffentlicht: (1995)

Associations of green tea and rock tea consumption with risk of impaired fasting glucose and impaired glucose tolerance in Chinese men and women.
von: Huibin Huang, et al.
Veröffentlicht: (2013-01-01)

Predicting risk for new-onset type 2 diabetes in Chinese people with coronary heart disease and impaired glucose tolerance

Ähnliche Einträge

Ähnliche Einträge